Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MRT-2359
i
Other names:
MRT-2359, GSPT1-directed MGD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Monte Rosa Therap
Drug class:
GSPT1 degrader
Related drugs:
‹
ORM-5029 (2)
CC-90009 (2)
ORM-5029 (2)
CC-90009 (2)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
MYCL expression
Non Small Cell Lung Cancer
MYCL expression
Non Small Cell Lung Cancer
MRT-2359
Sensitive: B - Late Trials
MRT-2359
Sensitive
:
B
MRT-2359
Sensitive: B - Late Trials
MRT-2359
Sensitive
:
B
MYCN expression
Non Small Cell Lung Cancer
MYCN expression
Non Small Cell Lung Cancer
MRT-2359
Sensitive: B - Late Trials
MRT-2359
Sensitive
:
B
MRT-2359
Sensitive: B - Late Trials
MRT-2359
Sensitive
:
B
MYC overexpression
Non Small Cell Lung Cancer
MYC overexpression
Non Small Cell Lung Cancer
MRT-2359
Sensitive: D – Preclinical
MRT-2359
Sensitive
:
D
MRT-2359
Sensitive: D – Preclinical
MRT-2359
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login